Novo Nordisk Aktie
WKN: 866931 / ISIN: US6701002056
24.03.2025 14:22:13
|
Novo Nordisk Expands $499 Wegovy Savings Offer To All Cash-paying Patients
(RTTNews) - Novo Nordisk (NVO) has expanded its $499 per month Wegovy savings program to include all cash-paying patients. Till now, the reduced price offer was only available with NovoCare pharmacy.
Wegovy injection is prescribed to reduce the risk of major cardiovascular events in adults with known heart disease and with either obesity or overweight.
In the pre-market trading, Novo Nordisk is 2.46% lesser at $74.97 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novo Nordisk (spons. ADRs)mehr Nachrichten
Analysen zu Novo Nordisk (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Novo Nordisk (spons. ADRs) | 47,35 | -1,76% |
|